Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > EBIT

Arbutus Biopharma Cp EBIT Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly EBIT from 2010 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Arbutus Biopharma Cp EBIT for the quarter ending December 12, 2018 was $-16m a -5.93% increase of 1m year over year
  • Arbutus Biopharma Cp EBIT for the last 12 months ending December 12, 2018 was $-70m a 7.95% decrease of -6m year over year
  • Arbutus Biopharma Cp Annual EBIT for 2018 was $-70m a 5.84% decrease of -4m from 2017
  • Arbutus Biopharma Cp Annual EBIT for 2017 was $-66m a -3.32% increase of 2m from 2016
  • Arbutus Biopharma Cp Annual EBIT for 2016 was $-68m a 25.24% decrease of -17m from 2015
Other Income Statement Metrics:
  • Arbutus Biopharma Cp EBITDA for the quarter ending December 12, 2018 was $-15m a -5.44% increase of 1m year over year
  • Arbutus Biopharma Cp Net Income for the quarter ending December 12, 2018 was $-18m a 4.70% decrease of -1m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS EBIT Data

12/2018$-16m
09/2018$-18m
06/2018$-20m
03/2018$-17m
12/2017$-24m
09/2017$-13m
06/2017$-19m
03/2017$-18m
12/2016$-19m
09/2016$-16m

Annual ABUS EBIT Data

2018$-70m
2017$-66m
2016$-68m
2015$-51m
2014$-33m
2013$-12m
2012$-13m
2011$-11m
2010$-7m
2009$-8m